Peter Voser Reports 355 Promised Fee Shares on IBM Form 4
Rhea-AI Filing Summary
Peter R. Voser, an IBM director, reported a non-derivative acquisition dated 09/30/2025 of 355 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The filing shows a per-share reference price of $282.16 and indicates 30,918 shares beneficially owned by Mr. Voser following the reported transaction. The Promised Fee Shares are deferrals of director fees that are paid out after retirement in common stock or cash, and distribution is deferred until retirement according to the plan terms.
Positive
- Director elected to defer fees into company stock, aligning compensation with long-term shareholder interests
- Ownership increased by 355 Promised Fee Shares, indicating continued director stake in the company
Negative
- None.
Insights
TL;DR: Director deferred fees into company stock, modestly increasing ownership while aligning compensation with long-term shareholder outcomes.
The filing documents a routine election by a director to defer board fees into Promised Fee Shares under IBM's deferred compensation plan. The addition of 355 shares is small relative to total holdings of 30,918 shares and appears designed to preserve tax or retirement timing rather than signal a material change in control or outlook. The deferred nature until retirement reduces immediate liquidity and aligns director incentives with long-term company performance. No indication of option exercise, sale, or other unusual transactions is present.
TL;DR: Routine Section 16 filing; transaction is a fee deferral, not a market purchase or sale, so investor impact is minimal.
The report shows a non-derivative acquisition through plan deferral with a stated reference price of $282.16 and resulting beneficial ownership of 30,918 shares. Because the shares are "promised" and payable at retirement, they do not represent an immediate change in tradable supply. This filing is informational for compliance and transparency but is unlikely to be material to IBM's valuation or near-term trading dynamics.